Quick Takeaways
- JPMORGAN CHASE & CO filed SCHEDULE 13G for TENAYA THERAPEUTICS, INC. Common Stock, par value $0.0001 per share (TNYA).
- Disclosed ownership: 6.5%.
- Date of event: 31 Dec 2024.
JPMORGAN CHASE & CO - 31 Dec 2024 SCHEDULE 13G Report for TENAYA THERAPEUTICS, INC. Common Stock, par value $0.0001 per share (TNYA)
- Filing Manager
- JPMORGAN CHASE & CO
- Reporting Manager
- JPMORGAN CHASE & CO.
- Symbol
- TNYA
- Shares outstanding
- 79,306,923 shares
- Disclosed Ownership
- 5,154,950 shares
- Ownership
- 6.5%
- Form type
- SCHEDULE 13G
- Filing time
- 10 Feb 2025, 12:51:48 UTC
- Date of event
- 31 Dec 2024
- Next filing
- 06 Mar 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"JPMORGAN CHASE & CO disclosed 6.5% ownership in TENAYA THERAPEUTICS, INC. Common Stock, par value $0.0001 per share (TNYA) on 31 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 10 Feb 2025, 12:51.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| JPMORGAN CHASE & CO. | 6.5% | 5,154,950 | 4,436,821 | 0 | Rachel Tsvaygoft | Vice President |